| Literature DB >> 32551365 |
Shiyong Liu1, Yan Li2, Konstantinos P Triantis3, Hong Xue4, Youfa Wang5.
Abstract
This study systematically examines the diffusion of the discrete event simulation (DES) approach in health services and health care management by examining relevant factors such as research areas, channels with the objective of promoting the application of DES in the health field. We examined 483 journal papers referencing this approach that were published in 230 journals during 1981 to 2014. The application of DES has extended from health service operational research evaluation to the assessment of interventions in diverse health arenas. The increase in the number of adopters (paper authors) of DES and the increase in number of related channels (journals publishing DES-related articles) are highly correlated, which suggests an increase of DES-related publications in health research. The same conclusion is reached, that is, an increased diffusion of DES in health research, when we focus on the temporal trends of the channels and adopters. The applications of DES in health research cover 22 major areas based on our categorization. The expansion in the health areas also suggests to a certain extent the rapid diffusion of DES in health research.Entities:
Keywords: adopters; channels; diffusion; discrete event simulation; health care management; health services
Year: 2020 PMID: 32551365 PMCID: PMC7278318 DOI: 10.1177/2381468320915242
Source DB: PubMed Journal: MDM Policy Pract ISSN: 2381-4683
Two Major Groups of Literature Review Regarding DES’s Application in Health Studies Done During 1981 to 2014.
| Application of DES in Particular Health-Related Areas | Comparison Between DES and Other Simulation Tools in Health Research |
|---|---|
| DES to resources allocation and planning in the health sector[ | DES and SD are preferable to capture interactions between individuals in economic evaluation of health interventions[ |
| Situations where DES can be applied in health care clinics[ | SD and DES to address strategic health care delivery issues[ |
| Breadth, quality, and value of DES for health service delivery[ | DT, MM, and DES for cost-effectiveness analysis of interventions using coronary heart disease as an example[ |
| Employing DES to identify real problems in critical care[ | Providing guidelines for using DES, ABM, SD, and MM in pharmacoeconomic and health technology assessment[ |
| Using DES for pharmacoeconomic analysis and to inform policy makers of the economic implications of pharmaceutical intervention[ | Suggest to use SD, SNA, ABM, DES, MM, and Soft System to integrate the behavioral and social sciences into the NIH scientific enterprises for addressing health disparities among populations[ |
| DES’s application in economic evaluation of the health care system[ | Use of DES and ABM in different levels of implementations[ |
| Potential of using DES in health care settings[ | Use SD, ABM, DES, and social networking analysis to develop public health policies and inform their implementation[ |
| Using DES to evaluate economic and clinical outcomes of imaging technology in health services[ | To facilitate the understanding of how SD, ABM, and DES can address various health care issues[ |
| Using DES to address typical administrative issues faced by health care managers[ | Application of SD, ABM, and DES in modeling patient flow issues in surgical care[ |
| Whether DES in health care has the necessary sense of urgency to deal with a much-needed reality check[ | Regression models, time-series analyses, queuing theory, and DES in studying emergency department patient flow/crowding[ |
| DES in performance modeling in health care[ | MC, MM, and DES to assess the cost effectiveness of drug treatment strategies for HIV infection[ |
| DES in assessing the cost-effectiveness of health technology for heart failure[ | SD, DES, and ABM in childhood obesity research[ |
| Operational issues of using DES in different health care contexts[ | Cohort MM and DES in evaluating clinical outcomes and utility for the treatment of chronic lymphocytic leukemia[ |
| DES to address patient flow issues in health care clinics and integrated health care systems[ | Application of DES and MM in economic evaluation of pharmacotherapeutics in patients with bipolar disorder[ |
| DES to model full guideline pathways for cost-effectiveness analysis of diagnostic and treatment pathways[ | Comparison of the advantages and disadvantages of using MM and DES in conducting a cost-effectiveness analysis[ |
| DES models for conducting cost and benefit analysis of health technologies in health care[ | Relationship among DES, MM, and DT in evaluating the cost-effectiveness of the treatment of chronic schizophrenia[ |
ABM, agent-based models; DES, discrete event simulation; DT, decision trees; MC, Monte Carlo simulation; MM, Markov models; SD, system dynamics; SNA, social network analysis.
List of Inclusion and Exclusion Criteria and Search Terms[a]
| Exclusion Criteria | Inclusion Criteria |
|---|---|
| 1. Non-journal papers | 1. English language |
| Search Items | |
| 1. Healthcare | a. Simulation |
For search items, they have “OR” relationship in a column, the items have “AND” relationship in different columns. For example, “hospital management” OR “public health” OR “healthcare.” The items in different columns have AND relationship such as “emergency management” AND “discrete event simulation.”
Figure 1Flowchart of the process of literature review, data acquisition and analysis.
Figure 2Trend in health-related research publications using discrete event simulation (DES) during 1981 to 2014.
Annual New Adopters and Channels for Publishing Discrete Event Simulation (DES)-Based Health-Related Research during 1981 to 2014[a]
| Year | Annual New Channels | Percentage | Cumulative Percentage | Annual New Adopters | Percentage | Cumulative Percentage |
|---|---|---|---|---|---|---|
| 1981 | 3 | 1.30% | 1.30% | 10 | 0.66% | 0.66% |
| 1982 | 0 | 0.00% | 1.30% | 0 | 0.00% | 0.66% |
| 1983 | 0 | 0.00% | 1.30% | 0 | 0.00% | 0.66% |
| 1984 | 0 | 0.00% | 1.30% | 0 | 0.00% | 0.66% |
| 1985 | 1 | 0.43% | 1.74% | 1 | 0.07% | 0.72% |
| 1986 | 3 | 1.30% | 3.04% | 3 | 0.20% | 0.92% |
| 1987 | 1 | 0.43% | 3.48% | 5 | 0.33% | 1.25% |
| 1988 | 1 | 0.43% | 3.91% | 2 | 0.13% | 1.38% |
| 1989 | 1 | 0.43% | 4.35% | 3 | 0.20% | 1.57% |
| 1990 | 1 | 0.43% | 4.78% | 2 | 0.13% | 1.71% |
| 1991 | 0 | 0.00% | 4.78% | 0 | 0.00% | 1.71% |
| 1992 | 2 | 0.87% | 5.65% | 4 | 0.26% | 1.97% |
| 1993 | 2 | 0.87% | 6.52% | 5 | 0.33% | 2.30% |
| 1994 | 3 | 1.30% | 7.83% | 3 | 0.20% | 2.49% |
| 1995 | 2 | 0.87% | 8.70% | 2 | 0.13% | 2.62% |
| 1996 | 7 | 3.04% | 11.74% | 18 | 1.18% | 3.81% |
| 1997 | 5 | 2.17% | 13.91% | 12 | 0.79% | 4.59% |
| 1998 | 3 | 1.30% | 15.22% | 18 | 1.18% | 5.77% |
| 1999 | 3 | 1.30% | 16.52% | 12 | 0.79% | 6.56% |
| 2000 | 3 | 1.30% | 17.83% | 25 | 1.64% | 8.20% |
| 2001 | 4 | 1.74% | 19.57% | 13 | 0.85% | 9.06% |
| 2002 | 4 | 1.74% | 21.30% | 24 | 1.57% | 10.63% |
| 2003 | 9 | 3.91% | 25.22% | 40 | 2.62% | 13.25% |
| 2004 | 10 | 4.35% | 29.57% | 57 | 3.74% | 16.99% |
| 2005 | 8 | 3.48% | 33.04% | 65 | 4.27% | 21.26% |
| 2006 | 11 | 4.78% | 37.83% | 41 | 2.69% | 23.95% |
| 2007 | 16 | 6.96% | 44.78% | 113 | 7.41% | 31.36% |
| 2008 | 21 | 9.13% | 53.91% | 98 | 6.43% | 37.80% |
| 2009 | 15 | 6.52% | 60.43% | 89 | 5.84% | 43.64% |
| 2010 | 10 | 4.35% | 64.78% | 132 | 8.66% | 52.30% |
| 2011 | 13 | 5.65% | 70.43% | 114 | 7.48% | 59.78% |
| 2012 | 24 | 10.43% | 80.87% | 223 | 14.63% | 74.41% |
| 2013 | 23 | 10.00% | 90.87% | 172 | 11.29% | 85.70% |
| 2014 | 21 | 9.13% | 100.00% | 218 | 14.30% | 100.00% |
| Total | 230 | 1524 |
Annul new channels indicate the annual number of journals that started to publish DES-based papers in the health-related field, which did not publish previously. Annual new adopters indicate the annual number of authors that started to publish DES-based papers in the health-related field.
The Ranking of Journals in Terms of the Number of Health Research Papers Using Discrete Event Simulation (DES) Published during 1981 to 2014[a]
| Rank | Journal Name | # of Papers[ | % | Cumulative % | Publication Period | Impact Factors, 2013–2014[ |
|---|---|---|---|---|---|---|
| 1 |
| 34 | 7.02% | 7.02% | 1998–2014 | 0.871 |
|
|
|
|
|
|
|
|
| 3 |
| 21 | 4.34% | 16.94% | 1985–2011 | 0.91 |
| 4 |
| 20 | 4.13% | 21.07% | 1993–2014 | 2.698 |
| 5 |
| 15 | 3.10% | 24.17% | 2007–2014 | 2.891 |
| 6 |
| 11 | 2.27% | 26.45% | 1987–2012 | 1.843 |
|
|
|
|
|
|
|
|
| 8 |
| 10 | 2.07% | 30.79% | 1981–2012 | 0.656 |
|
|
|
|
|
|
|
|
| 10 |
| 9 | 1.86% | 34.50% | 2002–2012 | 1.372 |
| 11 |
| 8 | 1.65% | 36.16% | 2007–2014 | 0 |
| 12 |
| 7 | 1.45% | 37.60% | 2010–2014 | 0 |
|
|
|
|
|
|
|
|
| 14 |
| 6 | 1.24% | 40.08% | 2006–2010 | 2.372 |
|
|
|
|
|
|
|
|
| 16 |
| 5 | 1.03% | 42.15% | 2004–2014 | 0 |
| 17 |
| 4 | 0.83% | 42.98% | 2004–2013 | 2.198 |
| 18 |
| 4 | 0.83% | 43.80% | 2013–2014 | 0 |
| 19 |
| 4 | 0.83% | 44.63% | 2001–2011 | 1.093 |
| 20 |
| 4 | 0.83% | 45.45% | 2007–2014 | 1.556 |
| 21 |
| 4 | 0.83% | 46.28% | 2011–2014 | 1.05 |
| 22 |
| 3 | 0.62% | 46.90% | 2006–2013 | 1.883 |
| 23 |
| 3 | 0.62% | 47.52% | 2008–2014 | 1.659 |
| 24 |
| 3 | 0.62% | 48.14% | 2007–2014 | 2.32 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 27 |
| 3 | 0.62% | 50.00% | 2001–2004 | 2.087 |
| 28 |
| 3 | 0.62% | 50.62% | 2005–2011 | 2.303 |
|
|
|
|
|
|
|
|
The table also uses 2013–2014 impact factors for these journals.
The journals that published <3 papers are not listed, but are available from the first author if requested.
Journals with a 2013–2014 impact factor >3 are highlighted.
Distribution of Health Research Areas Using Discrete Event Simulation (DES) during 1981 to 2014[a]
| No. | Research Areas | Number of Papers | % | Cumulative % | First Year to Publish |
|---|---|---|---|---|---|
| 1 | Improving health service at hospital/clinics/pharmacy | 167 | 34.58% | 34.58% | 1981 |
| 2 | Evaluating different treatment strategies and/or medicines for diseases | 102 | 21.12% | 55.69% | 2000 |
| 3 | Modeling progression/evolution of disease and treatment outcome | 30 | 6.21% | 61.90% | 1997 |
| 4 | Planning health service capacity at community or state | 25 | 5.18% | 67.08% | 1985 |
| 5 | Compare DES with other modeling tools | 23 | 4.76% | 71.84% | 2003 |
| 6 | Evaluating screening technology and policy for disease | 22 | 4.55% | 76.40% | 1996 |
| 7 | Review of DES in different areas of health research | 17 | 3.52% | 79.92% | 1995 |
| 8 | Modeling logistics of health service products | 13 | 2.69% | 82.61% | 2007 |
| 9 | Microlevel simulation, body physiology, drug dynamics | 13 | 2.69% | 85.30% | 1981 |
| 10 | Planning health service capacity for emergency event | 12 | 2.48% | 87.78% | 1999 |
| 11 | Modeling spread of contagious disease | 12 | 2.48% | 90.27% | 1990 |
| 12 | Evaluating the impact of health technology on health service | 12 | 2.48% | 92.75% | 1988 |
| 13 | Evaluating prevention strategies for contagious diseases (contagious disease and infection at hospital | 7 | 1.45% | 94.20% | 2005 |
| 14 | Improvement of clinical trial | 5 | 1.04% | 95.24% | 2008 |
| 15 | Understanding health care systems beyond hospital/clinics/pharmacy | 5 | 1.04% | 96.27% | 2001 |
| 16 | Evaluating the interventions to substance abuse | 4 | 0.83% | 97.10% | 1996 |
| 17 | Modeling medicine development and production process | 4 | 0.83% | 97.93% | 2004 |
| 18 | Modeling disease epidemiology | 3 | 0.62% | 98.55% | 2011 |
| 19 | Evaluating prevention strategies for noncontagious diseases | 2 | 0.41% | 98.96% | 2002 |
| 20 | Improvement of medical education | 2 | 0.41% | 99.38% | 2000 |
| 21 | Improving diagnosis process and procedures (sampling policies) | 2 | 0.41% | 99.79% | 2012 |
| 22 | Negative externalities of health issue | 1 | 0.21% | 100.00% | 2014 |
| Total | 483 | ||||
Research areas are primarily categorized based on the MeSH headings on PubMed. Some areas having unique characteristics are also labeled as different areas. Table 6 provides more detailed explanation on the area categorization.
Health Research Areas Using Discrete Event Simulation (DES) during 1981 to 2014[a]
| No. | Research Areas | Specific Research Questions, Topics, and Content |
|---|---|---|
| 1 | Improving health service at hospital/clinics/pharmacy/emergency department (ED) | Issues related to patient flow, appointment scheduling, bed (other capacity) planning, changes in policies, operating room utilization, resource allocating, access/admission management, performance management, waiting time, boarding in ED, training improvement, ambulance diversion, ambulance response time |
| 2 | Evaluating different treatment strategies and/or medicines for diseases | Evaluating cost-effectiveness and clinical outcomes of different medicines and/or treatment strategies & protocols & courses, benefits (quality of life) and risk evaluation of treatment and surgery operation |
| 3 | Modeling progression/evolution of disease and treatment outcome | Modeling progression of disease (including external factor on evolution) and intervention costs (including cancer and malignant tumor, major depression, asthma, Alzheimer, diabetes, heart disease, coronary events) |
| 4 | Planning health service capacity beyond hospital/clinics | Planning and budgeting for health service capacity beyond hospital level, i.e., health care network, pharmacy system, community, state, national levels |
| 5 | Evaluating screening technology and policies for disease | Economic and/or risk evaluation of screening policies, diagnosis, risk assessment schemes, technologies |
| 6 | Compare DES with other modeling tools | Compare DES with SD, DT, MM in the application of modeling patient flow, evaluating cost-effectiveness and clinical outcome of different medicines and treatments, allocating health care resources |
| 7 | Review of DES in different areas of health research | Review of DES in resource allocation/planning, economic evaluation of health care system, cost and benefit analysis of health technologies, pharmacoeconomic analysis, performance modeling |
| 8 | Modeling logistics of health service products | Modeling supply chain management and logistics, i.e., blood, vaccine, medical oxygen |
| 9 | Microlevel simulation, body physiology, drug dynamics | Human body microlevel simulation, i.e., metabolic network, gene expression, nucleation process, physiology process, drug dynamics, in vivo tumor response to therapy |
| 10 | Planning health service capacity for emergency events | Incidents of urban terrorism, mass casualty, bioattack, outbreak of epidemic diseases such as smallpox |
| 11 | Modeling spread of contagious disease | Spread and transmission of contagious diseases, e.g., AIDS pandemic, malaria, Lyme disease, TB, H5N1 |
| 12 | Evaluating impacts of health technology on health service | Impact of health technology on service performance, cost-effectiveness, efficiency of health service delivery |
| 13 | Evaluating prevention strategies for contagious diseases (contagious disease and infection at hospital) | Prevention strategies for mother-to-child transmission of HIV, pandemic influenza, herpes zoster, infection control such as methicillin-resistant |
| 14 | Improvement of clinical trial | Improving design and study of clinical trials such as phase I pediatric oncology, agile study design |
| 15 | Understanding health care systems beyond single hospital/clinics/pharmacy | Hospital-at-home initiatives, physician network setting, communication process of stakeholder in health care systems, change program at national level, performance of family health units versus primary health care centers |
| 16 | Evaluating the intervention to substance abuse | Evaluating health and/or economic impact of interventions, i.e., smoking cessation program and treatment |
| 17 | Modeling medicine development and production process | New medicine development, production process of antibody production, facility design for medicine |
| 18 | Prevention strategies for noncontagious diseases | Evaluating prevention strategies for coronary heart disease, occupational disease, i.e., low back pain |
| 19 | Modeling disease epidemiology | Estimating prevalence of disease and health care costs (acquired brain damage, hypertension, chronic diseases) |
| 20 | Improvement of medical education | Improving understanding on the workflow processes using simulation tool |
| 21 | Improving diagnosis process and procedures | Evaluating different sampling policies to find cost-effective alternatives to pathologists |
| 22 | Negative externalities of health issue | Evaluating impact of health issues on national labor supply |
DT, decision trees; MM, Markov models; SD, system dynamics; TB, tuberculosis.
Research areas are primarily categorized based on the MeSH headings on PubMed. Some areas having unique characteristics are also labeled as different areas.
Publications Over Years in Applying Discrete Event Simulation (DES) to Different Areas of Health Research during 1981 to 2014a
| Year ↓ | Publication Number Over Years in Areas of Health-Related Study Using Discrete Event Simulation | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Areas → | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 |
| 1981 | 1 | 2 | ||||||||||||||||||||
| 1982 | 0 | 0 | ||||||||||||||||||||
| 1983 | 0 | 0 | ||||||||||||||||||||
| 1984 | 1 | 0 | ||||||||||||||||||||
| 1985 | 0 | 2 | 0 | |||||||||||||||||||
| 1986 | 0 | 2 | 1 | |||||||||||||||||||
| 1987 | 2 | 1 | 0 | |||||||||||||||||||
| 1988 | 0 | 0 | 0 | 1 | ||||||||||||||||||
| 1989 | 1 | 0 | 0 | 0 | ||||||||||||||||||
| 1990 | 0 | 0 | 0 | 1 | 0 | |||||||||||||||||
| 1991 | 0 | 0 | 0 | 0 | 0 | |||||||||||||||||
| 1992 | 1 | 1 | 0 | 0 | 0 | |||||||||||||||||
| 1993 | 1 | 0 | 0 | 0 | 1 | |||||||||||||||||
| 1994 | 3 | 1 | 0 | 0 | 0 | |||||||||||||||||
| 1995 | 1 | 1 | 1 | 0 | 0 | 1 | ||||||||||||||||
| 1996 | 5 | 0 | 2 | 0 | 0 | 1 | 0 | 1 | ||||||||||||||
| 1997 | 3 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | |||||||||||||
| 1998 | 2 | 0 | 1 | 0 | 0 | 0 | 1 | 2 | 0 | |||||||||||||
| 1999 | 2 | 0 | 0 | 0 | 1 | 0 | 1 | 2 | 0 | 0 | ||||||||||||
| 2000 | 1 | 2 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 1 | ||||||||||
| 2001 | 4 | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 1 | 0 | 2 | 0 | 0 | |||||||||
| 2002 | 2 | 1 | 2 | 1 | 2 | 0 | 0 | 1 | 0 | 0 | 1 | 0 | 1 | 0 | ||||||||
| 2003 | 6 | 2 | 0 | 0 | 1 | 3 | 2 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | |||||||
| 2004 | 5 | 1 | 0 | 1 | 1 | 1 | 1 | 2 | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | ||||||
| 2005 | 3 | 6 | 0 | 3 | 1 | 2 | 1 | 2 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | |||||
| 2006 | 4 | 6 | 3 | 0 | 1 | 1 | 2 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | |||||
| 2007 | 12 | 9 | 3 | 1 | 2 | 1 | 1 | 1 | 1 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | ||||
| 2008 | 13 | 8 | 0 | 3 | 3 | 1 | 0 | 1 | 1 | 0 | 2 | 0 | 0 | 3 | 0 | 0 | 0 | 0 | 0 | |||
| 2009 | 13 | 7 | 2 | 1 | 1 | 0 | 2 | 0 | 0 | 0 | 1 | 0 | 3 | 1 | 0 | 0 | 0 | 1 | 1 | |||
| 2010 | 13 | 11 | 3 | 0 | 2 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | |||
| 2011 | 14 | 7 | 3 | 0 | 3 | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 1 | 0 | 1 | 0 | 0 | ||
| 2012 | 15 | 16 | 5 | 0 | 1 | 2 | 0 | 4 | 1 | 5 | 1 | 3 | 1 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 1 | |
| 2013 | 21 | 11 | 4 | 3 | 3 | 0 | 3 | 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 1 | |
| 2014 | 18 | 15 | 4 | 2 | 4 | 3 | 1 | 2 | 1 | 2 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 2 | 0 | 0 | 0 | 1 |
| Total | 167 | 102 | 30 | 26 | 23 | 22 | 17 | 13 | 11 | 12 | 12 | 12 | 7 | 5 | 5 | 4 | 4 | 3 | 2 | 2 | 2 | 1 |